Hartmut Ney

USPTO Granted Patents = 12 (Patent Applications = 7)

CIPO Patents = 2

EPO Patents = 7 (Patent Applications = 2)

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 130(Granted Patents)

Location History:

Konstanz, DE (2014)
Constance, DE (1999 - 2016)

Company Filing History:

Byk Gulden Lomberg Chemische Fabrik Gmbh

Years Active: 1999-2016

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9468598 - Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient (2016-10-18),

2. 8758817 - Dosage form containing (S)-pantoprazole as active ingredient (2014-06-24),

3. 8703192 - Dosage form containing pantoprazole as active ingredient (2014-04-22),

4. 8465767 - Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles (2013-06-18),

5. 8431154 - Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient (2013-04-30),

6. 7951398 - Pharmaceutical preparation comprising an active dispersed on a matrix (2011-05-31),

7. 7951397 - Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient (2011-05-31),

8. 7402321 - Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles (2008-07-22),

9. 7175854 - Pharmaceutical preparation comprising an active dispersed on a matrix (2007-02-13),

10. 7147869 - Rapidly disintegrating tablet comprising an acid-labile active ingredient (2006-12-12),

11. 7041313 - Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles (2006-05-09),

12. 5997903 - Oral-administration forms of a medicament containing pantoprazol (1999-12-07),

Title: Hartmut Ney: Innovator in Pharmaceutical Formulations

Introduction

Hartmut Ney is a distinguished inventor based in Constance, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. With a total of 12 patents to his name, Ney's work has had a considerable impact on medication delivery systems.

Latest Patents

Among his latest patents, Ney has developed an oral dosage form containing a PDE 4 inhibitor as an active ingredient, utilizing polyvinylpyrrolidone (PVP) as an excipient. This innovation addresses the challenges associated with the solubility of PDE 4 inhibitors, providing effective dosage forms for oral administration. Another notable patent involves a dosage form containing (S)-pantoprazole as the active ingredient, specifically focusing on the magnesium salt of (S)-pantoprazole for oral administration.

Career Highlights

Throughout his career, Hartmut Ney has worked with prominent companies in the pharmaceutical industry, including Takeda GmbH and Nycomed GmbH. His expertise in formulation science has been instrumental in advancing drug delivery technologies.

Collaborations

Ney has collaborated with notable colleagues such as Rango Dietrich and Rudolf Linder, contributing to various projects that enhance pharmaceutical formulations.

Conclusion

Hartmut Ney's innovative work in the pharmaceutical sector exemplifies the importance of research and development in improving medication delivery. His patents reflect a commitment to enhancing patient care through effective drug formulations.

This text is generated by artificial intelligence and may not be accurate.